FreeCME

The Power of SGLT2 Inhibitors to Improve Renal Outcomes in CKD

CME: 1.0

March 31, 2021
KEYWORDS Primary Care
/ Print / Reprints /
| Share More
/ Text Size+

Post a comment to this article